Toward Personalized Risk Stratification in Advanced Follicular Thyroid Carcinoma.
This nomogram provides a population-level estimate of DSS in advanced FTC and may support preliminary risk stratification using readily available registry variables, but its clinical interpretation should consider the absence of key biologic and treatment-response factors not captured in SEER, including vascular invasion, molecular alterations, and systemic therapy data.